The enhanced differential diagnostic efficacy of DCP to distinguish between HCC and liver cirrhosis and its high capacity for identifying HCC with negative AFP are important complements to AFP because an elevation in AFP could occur in approximately 11–47% of subjects with liver cirrhosis, and a false-negative AFP appeared in 30–40% of subjects with HCC [29]. The gene discussed is AFP; the disease is cirrhosis of liver.